This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting on Oct 28 to consider Q2/H1 FY26 results
BOROSCI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.2 pts more than Nifty Microcap 250 and 5.6 pts more than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Borosil Scientific has informed BSE that its Board of Directors will meet on Wednesday, October 28, 2026, to consider and approve the Unaudited Financial Results (standalone and consolidated) for the quarter and half year ended September 30, 2026. The trading window for dealing in shares by designated persons and their immediate relatives, already closed from October 1, 2026, will remain closed until 48 hours after the results are declared.
Routine intimation ahead of Q2 results. Investors should watch for the actual numbers on or after October 28, 2026.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹115.0 Cr | ₹106.9 Cr | +7.5% |
| Operating profit | ₹5.26 Cr | ₹2.99 Cr | +76.3% |
| Profit after tax | ₹5.31 Cr | ₹2.85 Cr | +86.4% |
| EBITDA margin | 9.3% | 7.5% | +1.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.